Abstract Radiotherapy combined with immune checkpoint blockade holds great promise for synergistic antitumor efficacy. Targeted radionuclide therapy delivers radiation directly to tumor sites. LNC1004 is a fibroblast activation protein (FAP)-targeting radiopharmaceutical. conjugated with the albumin binder Evans Blue. https://countryscenesaddleryandpetsuppliers.shop/product-category/stockyard-lariat/